ATE342994T1 - Verfahren zur gewinnung von proteinen aus der interstitiellen flüssigkeit von pflanzen - Google Patents

Verfahren zur gewinnung von proteinen aus der interstitiellen flüssigkeit von pflanzen

Info

Publication number
ATE342994T1
ATE342994T1 AT99939728T AT99939728T ATE342994T1 AT E342994 T1 ATE342994 T1 AT E342994T1 AT 99939728 T AT99939728 T AT 99939728T AT 99939728 T AT99939728 T AT 99939728T AT E342994 T1 ATE342994 T1 AT E342994T1
Authority
AT
Austria
Prior art keywords
plants
proteins
interstitial fluid
obtaining proteins
large scale
Prior art date
Application number
AT99939728T
Other languages
English (en)
Inventor
Thomas H Turpen
Stephen J Garger
Michael J Mcculloch
Terri I Cameron
Michelle L Samonek-Potter
R Barry Holtz
Original Assignee
Biosource Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosource Tech Inc filed Critical Biosource Tech Inc
Application granted granted Critical
Publication of ATE342994T1 publication Critical patent/ATE342994T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2422—Alpha-amylase (3.2.1.1.) from plant source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022—Alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/13—Immunoglobulins specific features characterized by their source of isolation or production isolated from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Fertilizers (AREA)
AT99939728T 1998-08-11 1999-08-11 Verfahren zur gewinnung von proteinen aus der interstitiellen flüssigkeit von pflanzen ATE342994T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13298998A 1998-08-11 1998-08-11

Publications (1)

Publication Number Publication Date
ATE342994T1 true ATE342994T1 (de) 2006-11-15

Family

ID=22456515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99939728T ATE342994T1 (de) 1998-08-11 1999-08-11 Verfahren zur gewinnung von proteinen aus der interstitiellen flüssigkeit von pflanzen

Country Status (14)

Country Link
US (5) US6284875B1 (de)
EP (1) EP1104479B1 (de)
JP (1) JP2002522559A (de)
KR (1) KR20010072372A (de)
AT (1) ATE342994T1 (de)
AU (1) AU759813B2 (de)
BR (1) BR9912875A (de)
CA (1) CA2349852A1 (de)
DE (1) DE69933677T2 (de)
IL (1) IL141312A0 (de)
MX (1) MXPA01001445A (de)
NZ (1) NZ510358A (de)
WO (1) WO2000009725A2 (de)
ZA (1) ZA200101100B (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ510358A (en) * 1998-08-11 2002-09-27 Large Scale Biology Corp Method for recovering proteins from the interstitial fluid of plant tissues
IL147343A0 (en) * 1999-07-21 2002-08-14 Large Scale Biology Corp Method for enhancing ran or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
DE60143959D1 (de) 2000-08-25 2011-03-10 Basf Plant Science Gmbh En kodieren
EP1436316B1 (de) * 2001-04-30 2008-01-23 ZyStor Therapeutics , Inc. Subzelluläres targeting von therapeutischen proteinen
US20040005309A1 (en) * 2002-05-29 2004-01-08 Symbiontics, Inc. Targeted therapeutic proteins
US7629309B2 (en) * 2002-05-29 2009-12-08 Zystor Therapeutics, Inc. Targeted therapeutic proteins
US7560424B2 (en) 2001-04-30 2009-07-14 Zystor Therapeutics, Inc. Targeted therapeutic proteins
US20030072761A1 (en) * 2001-10-16 2003-04-17 Lebowitz Jonathan Methods and compositions for targeting proteins across the blood brain barrier
US6817970B2 (en) * 2002-06-17 2004-11-16 Large Scale Biology Corporation Centrifuge for extracting interstitial fluid
CN101350215B (zh) * 2002-06-24 2012-08-29 Lg电子株式会社 记录和再现用于视频数据的再现的数据结构的方法及装置
KR20040000290A (ko) * 2002-06-24 2004-01-03 엘지전자 주식회사 고밀도 광디스크의 멀티 경로 데이터 스트림 관리방법
EP1629090B1 (de) * 2002-11-06 2014-03-05 iBio, Inc. Expression von fremdsequenzen in pflanzen unter verwendung eines trans-aktivierungssystems
US7692063B2 (en) * 2002-11-12 2010-04-06 Ibio, Inc. Production of foreign nucleic acids and polypeptides in sprout systems
US7683238B2 (en) * 2002-11-12 2010-03-23 iBio, Inc. and Fraunhofer USA, Inc. Production of pharmaceutically active proteins in sprouted seedlings
ES2531125T3 (es) 2003-02-03 2015-03-10 Ibio Inc Sistema para la expresión de genes en plantas
US7809775B2 (en) * 2003-02-27 2010-10-05 Lg Electronics, Inc. Recording medium having data structure for managing playback control recorded thereon and recording and reproducing methods and apparatuses
CN100397882C (zh) * 2003-02-28 2008-06-25 Lg电子株式会社 具有用于管理记录其上的视频数据的随机/洗牌重现的数据结构的记录媒体以及记录和重现的方法和装置
CN1833030B (zh) 2003-05-22 2014-07-23 美国弗劳恩霍夫股份有限公司 用于表达、传递及纯化目标多肽的重组载体分子
US8158379B2 (en) * 2003-10-28 2012-04-17 Allosource Methods for determining microbial contamination of allograft products
DE602005020745D1 (de) * 2004-02-10 2010-06-02 Zystor Therapeutics Inc Saure alpha-glukosidase und fragmente davon
ES2532609T3 (es) 2004-02-20 2015-03-30 Ibio, Inc. Sistemas y métodos para expresión clonales en plantas
US20050220901A1 (en) * 2004-03-22 2005-10-06 Huttenbauer Samuel Jr Methods of pharmaceutical separation from plants
WO2006004675A2 (en) 2004-06-25 2006-01-12 Altor Bioscience Corporation Production of tissue factor in plants
US20060288449A1 (en) * 2004-10-12 2006-12-21 Garger Stephen J Process for purifying target compounds from plant sources using ceramic filtration
US7960519B2 (en) * 2005-05-31 2011-06-14 Pierce Biotechnology, Inc. Extraction of cellular components with fatty acid derivatives
EP1919504B1 (de) * 2005-08-03 2013-10-16 iBio, Inc. Antikörper gegen bacillus anthracis protektiv antigen
US8124103B2 (en) * 2006-02-13 2012-02-28 Fraunhofer Usa, Inc Influenza antigens, vaccine compositions, and related methods
WO2007095320A2 (en) * 2006-02-13 2007-08-23 Fraunhofer Usa, Inc. Hpv antigens, vaccine compositions, and related methods
WO2008048344A2 (en) * 2006-02-13 2008-04-24 Fraunhofer Usa, Inc. Bacillus anthracis antigens, vaccine compositions, and related methods
TW200745337A (en) * 2006-02-24 2007-12-16 Aminotech As Modified process
AU2007322123A1 (en) * 2006-11-13 2008-05-29 Biomarin Pharmaceutical Inc. Methods for treating Pompe disease
CN101687024A (zh) * 2007-04-28 2010-03-31 美国弗劳恩霍夫股份有限公司 锥虫抗原、疫苗组合物和相关方法
WO2008143914A1 (en) * 2007-05-16 2008-11-27 The University Of Maryland, College Park Novel methods for recovery of leaf proteins
US8404252B2 (en) 2007-07-11 2013-03-26 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
WO2009076778A1 (en) 2007-11-27 2009-06-25 Medicago Inc. Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
CA2696764A1 (en) * 2007-08-20 2009-02-26 Fraunhofer Usa, Inc. Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
EP2113514A1 (de) 2008-05-03 2009-11-04 Westfälische Wilhelms-Universität Münster Verfahren zur Erzeugung von hypoallergenen Glykoproteinen in mutierten oder transgenen Pflanzen oder Pflanzenzellen sowie mutierte oder transgene Pflanzen und Pflanzenzellen zur Erzeugung hypoallergener Glykoproteine
WO2009137721A2 (en) 2008-05-07 2009-11-12 Zystor Therapeutics, Inc. Lysosomal targeting peptides and uses thereof
WO2010003235A1 (en) 2008-07-08 2010-01-14 Medicago Inc. Soluble recombinant influenza antigens
WO2010037046A1 (en) 2008-09-28 2010-04-01 Fraunhofer Usa, Inc. Humanized neuraminidase antibody and methods of use thereof
US8785168B2 (en) 2009-06-17 2014-07-22 Biomarin Pharmaceutical Inc. Formulations for lysosomal enzymes
BRPI1015053A2 (pt) 2009-06-24 2019-07-09 Medicago Inc partículas similares a vírus da influenza quiméricas compreendendo hemaglutinina
SI3354657T1 (sl) 2009-09-22 2022-05-31 Medicago Inc. Postopek za pripravo iz rastlin izpeljanih beljakovin
US8784819B2 (en) 2009-09-29 2014-07-22 Ibio Inc. Influenza hemagglutinin antibodies, compositions and related methods
WO2012012462A2 (en) 2010-07-19 2012-01-26 The Regents Of The University Of California Plant-based production of heterologous proteins
US9155321B2 (en) 2010-08-11 2015-10-13 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
PH12013500719A1 (en) 2010-10-27 2013-05-20 Philip Morris Products Sa Methods for capturing virus like particles from plants using expanded bed chromatography
US9204667B2 (en) 2010-12-01 2015-12-08 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products
US9775376B2 (en) 2010-12-01 2017-10-03 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
US9220295B2 (en) 2010-12-01 2015-12-29 R.J. Reynolds Tobacco Company Tobacco separation process for extracting tobacco-derived materials, and associated extraction systems
TWI620816B (zh) * 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
US20130118512A1 (en) 2011-11-16 2013-05-16 R.J. Reynolds Tobacco Company Smokeless tobacco products with starch component
US20130125904A1 (en) 2011-11-18 2013-05-23 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising pectin component
WO2013119419A1 (en) 2012-02-08 2013-08-15 North Carolina State University Treatment of allergic diseases with recombinant antibodies
US12285025B2 (en) 2012-02-10 2025-04-29 R.J. Reynolds Tobacco Company Multi-layer smokeless tobacco composition
US9339058B2 (en) 2012-04-19 2016-05-17 R. J. Reynolds Tobacco Company Method for producing microcrystalline cellulose from tobacco and related tobacco product
US9617297B2 (en) * 2012-10-11 2017-04-11 The Regents Of The University Of California Apoplast wash fluid recovery for improved recombinant endoglucanase extraction in tabacco leaves
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
CN104195170B (zh) * 2014-09-16 2016-04-13 云南省农业科学院生物技术与种质资源研究所 一种水稻真空渗透遗传转化方法
US10869497B2 (en) 2015-09-08 2020-12-22 R.J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
US11612183B2 (en) 2015-12-10 2023-03-28 R.J. Reynolds Tobacco Company Protein-enriched tobacco composition
JP7127859B2 (ja) 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
US10757964B2 (en) 2017-07-20 2020-09-01 R.J. Reynolds Tobacco Company Purification of tobacco-derived protein compositions
BE1025528B1 (fr) * 2017-09-06 2019-04-05 Universite De Liege Établissement Public De La Communauté Française De Belgique Dispositif non-destructif d'echantillon pour extraction de marqueurs
WO2019183437A1 (en) 2018-03-23 2019-09-26 North Carolina State University Methods and compositions for antibody to high affinity receptor for ige
US20190307082A1 (en) 2018-04-05 2019-10-10 R.J. Reynolds Tobacco Company Oriental tobacco production methods
EP3801056A4 (de) 2018-05-30 2022-03-16 LeafPro, LLC. Gereinigte proteinkonzentrate von süssen kartoffelblättern und verfahren zur rückgewinnung
US11312753B2 (en) * 2018-09-25 2022-04-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems to produce lignin-modifying enzymes and uses thereof
WO2020148704A1 (en) 2019-01-18 2020-07-23 R. J. Reynolds Tobacco Company Plant-derived rubisco protein purification
EP3808854A1 (de) * 2019-10-17 2021-04-21 eleva GmbH Verfahren zur gewinnung von material von pflanzenzelloberflächen
MX2022006906A (es) 2019-12-09 2022-08-16 Nicoventures Trading Ltd Composiciones orales y metodos de fabricacion.
CN111004766B (zh) * 2019-12-30 2022-03-18 浙江大学 一种从植物叶片中提取纯化内质网及其蛋白的有效方法
US12703877B2 (en) 2020-06-05 2026-08-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems to secrete lignin-modifying enzymes and uses thereof
WO2022030600A1 (ja) * 2020-08-05 2022-02-10 デンカ株式会社 目的タンパク質の回収方法及び製造方法
US20220354785A1 (en) 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
MX2023012537A (es) 2021-04-22 2024-01-24 Nicoventures Trading Ltd Composiciónes orales y metodos de fabricacion.
EP4147785B1 (de) * 2021-09-10 2025-04-02 Alfa Laval Corporate AB Verfahren zur konzentration einer suspension auf pflanzlicher basis
JP7745040B1 (ja) 2024-06-21 2025-09-26 デンカ株式会社 目的タンパク質の回収方法及び製造方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910822A (en) * 1974-03-14 1975-10-07 Us Health Isolation of glucocerebrosidase from human placental tissue
JPS5322158B2 (de) * 1974-05-02 1978-07-06
JPS53107479A (en) * 1977-02-28 1978-09-19 Green Cross Corp:The Preparation of human lysozyme
US4885248A (en) 1984-02-15 1989-12-05 Lubrizol Genetics, Inc. Transfer vector
US5173410A (en) 1984-02-15 1992-12-22 Lubrizol Genetics Inc. Transfer vector
CA1288073C (en) 1985-03-07 1991-08-27 Paul G. Ahlquist Rna transformation vector
US5466788A (en) 1985-03-07 1995-11-14 Mycogen Plant Science, Inc. Subgenomic promoter
ES2060646T3 (es) 1987-02-09 1994-12-01 Lubrizol Genetics Inc Virus rna hibrido.
US5316931A (en) 1988-02-26 1994-05-31 Biosource Genetics Corp. Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
DE4016562A1 (de) * 1990-05-23 1991-11-28 Degussa Rohrverbindungsstuecke zur installation von rohrleitungen und verfahren zu ihrer herstellung
US5852172A (en) * 1991-06-13 1998-12-22 University Of Waterloo Cold tolerances in plants
US5597569A (en) * 1993-10-25 1997-01-28 Bristol-Myers Squibb Company Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica
CH688988A5 (de) * 1994-03-14 1998-07-15 Ferrum Ag Filterzentrifuge.
US5837826A (en) * 1995-02-27 1998-11-17 Regents Of The University Of Minnesota Protein adsorption by very dense porous zirconium oxide particles in expanded beds
ES2124176B1 (es) * 1996-10-07 1999-10-01 Univ Valladolid Procedimiento para la obtencion de proteinas inactivadoras de ribosomas, denominadas beetin 27 y beetin 29, de las hojas de beta vulgaris (remolacha azucarera) infectadas con el virus de la amarillez.
NZ510358A (en) * 1998-08-11 2002-09-27 Large Scale Biology Corp Method for recovering proteins from the interstitial fluid of plant tissues

Also Published As

Publication number Publication date
EP1104479B1 (de) 2006-10-18
EP1104479A2 (de) 2001-06-06
BR9912875A (pt) 2002-02-13
DE69933677D1 (de) 2006-11-30
US20040047923A1 (en) 2004-03-11
US6841659B2 (en) 2005-01-11
AU5396799A (en) 2000-03-06
US7034128B2 (en) 2006-04-25
US6441147B1 (en) 2002-08-27
NZ510358A (en) 2002-09-27
ZA200101100B (en) 2001-11-26
US6284875B1 (en) 2001-09-04
MXPA01001445A (es) 2002-11-29
US20030073209A1 (en) 2003-04-17
WO2000009725A3 (en) 2000-05-18
US6617435B2 (en) 2003-09-09
WO2000009725A2 (en) 2000-02-24
US20050059127A1 (en) 2005-03-17
DE69933677T2 (de) 2007-08-23
JP2002522559A (ja) 2002-07-23
CA2349852A1 (en) 2000-02-24
KR20010072372A (ko) 2001-07-31
AU759813B2 (en) 2003-05-01
IL141312A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
DE69933677D1 (de) Verfahren zur gewinnung von proteinen aus der interstitiellen flüssigkeit von pflanzen
ATE517185T1 (de) Methoden zur herstellung von pflanzen mit erhöhtem ölsäuregehalt
WO2002046442A3 (en) Phosphatase stress-related proteins and methods of use in plants
ATE68830T1 (de) Verfahren zur erhoehung der ausbeute von heterologen proteinen, produziert durch zuechtung von rekombinanten bakterien.
DE60214400D1 (de) Verfahren zur proteinproduktion in pflanzen
ATE12255T1 (de) Verfahren zur herstellung von selbstreproduzierenden pankreatischen inseln aehnlichen strukturen von saeugetieren.
ATE484189T1 (de) Stressbedingte transkriptionsfaktorproteine und verwendungsverfahren für pflanzen
ATE312168T1 (de) Verfahren zur kultivierung von krebszellen aus humangewebe und vorrichtung zur aufbereitung von gewebeproben
IT7920779A0 (it) Metano e impianto per attuare tale procedimento per la produzione di procedimento.
ATE278773T1 (de) Verfahren zur expression und isolierung von rekombinanten proteinen und rekombinanten proteinprodukten von pflanzen, pflanzlichen geweben oder kultivierten pflanzenzellen
ATE309814T1 (de) Spermatophyte pflanzenextrakte mit antitumoraler wirkung
DK32684A (da) Fremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol og mellemprodukter til brug herfor
ATE330003T1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
DE502004007159D1 (de) Verfahren zur herstellung von flavonoid-haltigen zusammensetzungen und ihre verwendung
DE60138535D1 (de) Verwendung von lysosomal acid lipase zur behandlung von atherosklerose und ähnlichen krankheiten
IS6299A (is) Aðferð til vinnslu á efnum sem innihalda prótín
DE69732792D1 (de) Verfahren zur herstellung parthenokarper oder weiblich-steriler transgener pflanzen
IT1106138B (it) Procedimento per la produzione di peptidi analoghi alla somatostatina prodotto ottenuto e composizioni farmaceutiche che lo contengono come infrediente attivo
ATE159534T1 (de) Isolierung und reinigung eines oberflächenaktiven proteins aus lunge
ATE319847T1 (de) Verfahren zur erhöhung des gehaltes an schwefelverbindungen in pflanzen
EA199700310A1 (ru) Биологический способ получения соединений дипептидной природы
ATE541920T1 (de) Mit stress verbundene proteinphosphatase- polypeptide und verfahren zur verwendung in pflanzen
NO994852D0 (no) En ny prosess for aa fremstille stabilisert höykonsentrert diterpenfenolsyre
AU4671685A (en) Separation process with recovery of proteins & fats from substances of animal origin, organic substances or refluent from working organic substances & plant to carry out the
DE69032153D1 (de) Verfahren zur Herstellung von Butantetracarboxylat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties